Stanley H. Appel Department of Neurology

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Amyotrophic Lateral Sclerosis 93%
3. Alzheimer Disease 70%
4. Brain 66%
5. Restless Legs Syndrome 57%
6. Spinocerebellar Ataxia 10 47%
7. Stroke 46%
8. Motor Neurons 44%
9. Myotonic Dystrophy 43%
10. Tremor 36%
11. Neuroimaging 35%
12. Essential Tremor 35%
13. Positron-Emission Tomography 34%
14. Cognitive Dysfunction 34%
15. Dementia 34%
16. Spinocerebellar Ataxias 31%
17. Vascular Dementia 30%
18. Therapeutics 29%
19. Headache 28%
20. Mutation 26%
21. Genes 25%
22. Placebos 25%
23. Single-Photon Emission-Computed Tomography 24%
24. Biomarkers 24%
25. Ataxia 24%
26. Deep Brain Stimulation 24%
27. (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine 24%
28. Amyloid 22%
29. Neurology 21%
30. Pathology 20%
31. Huntington Disease 20%
32. White Matter 20%
33. Migraine Disorders 19%
34. Cholinergic Receptors 19%
35. Spinal Cord 19%
36. Cerebrospinal Fluid 19%
37. Disease Progression 19%
38. Muscles 19%
39. Magnetic Resonance Imaging 19%
40. Microglia 19%
41. Seizures 19%
42. Phenotype 19%
43. Neurodegenerative Diseases 18%
44. Pallidotomy 18%
45. Proteins 17%
46. Cognition 17%
47. Levodopa 16%
48. Age of Onset 16%
49. Parkinsonian Disorders 16%
50. Alleles 15%
51. Movement Disorders 15%
52. Gait 15%
53. Myasthenia Gravis 14%
54. Safety 14%
55. Machado-Joseph Disease 14%
56. Clinical Trials 14%
57. Skeletal Muscle 14%
58. Dystonia 14%
59. Blood Vessels 14%
60. Atrophy 13%
61. Neurons 13%
62. Friedreich Ataxia 13%
63. Membranes 13%
64. Population 13%
65. Nervous System Diseases 13%
66. Tropical Spastic Paraparesis 13%
67. Muscular Dystrophies 13%
68. Wounds and Injuries 13%
69. Neurologists 13%
70. Amyotrophic lateral sclerosis 1 12%
71. Rolipram 12%
72. Nervous System 12%
73. Brain Diseases 12%
74. Cerebellar Ataxia 12%
75. In Vitro Techniques 11%
76. Antibodies 11%
77. Dyskinesias 11%
78. Charcot-Marie-Tooth Disease 11%
79. Dopamine Plasma Membrane Transport Proteins 11%
80. Mental Status and Dementia Tests 11%
81. Epilepsy 11%
82. Injections 11%
83. Dopamine 11%
84. Immunoglobulin G 10%
85. Stuttering 10%
86. Frontotemporal Dementia 10%
87. Ligands 10%
88. GABA-A Receptors 10%
89. Dopamine Agonists 10%
90. Multiple Sclerosis 10%
91. Calcium 10%
92. Cholinergic Agents 10%
93. Fluorodeoxyglucose F18 10%
94. Memory 10%
95. Microsatellite Repeats 10%
96. Regulatory T-Lymphocytes 10%
97. Cerebellum 9%
98. Tomography 9%
99. Randomized Controlled Trials 9%
100. Inflammation 9%